Tukysa

(tucatinib)

TUKYSA 50 MG Oral TabletTUKYSA 150 MG Oral Tablet

NO BLACK BOX WARNING

Dosage & administration

* In patients with unresectable or metastatic colorectal cancer, confirm the presence of HER2 protein overexpression and RAS wild-type in tumor specimens prior to the initiation of TUKYSA
* Recommended dosage: 300 mg taken orally twice daily with or without food.
* For patients with severe hepatic impairment, the recommended dosage is 200 mg orally twice daily.

biomarker testing

Tukysa clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Tukysa prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Tukysa prior authorization resources

PDFCoverage Authorization Request

PDFCoverage Authorization Appeals

PDFPrior Authorization Process Guide

Learn More

Benefits investigation

PDFHealthcare Provider Request Form

PDFPatient Authorization Form

PDFHealthcare Provider Request Form - Spanish

PDFPatient Authorization Form - Spanish

Learn More

pharmacy

Tukysa preferred pharmacy

OTHERPharmacy List

financial assistance

Tukysa financial assistance options

Bridge program

commercial only

PDFHealthcare Provider Request Form

PDFPatient Authorization Form

PDFHealthcare Provider Request Form - Spanish

PDFPatient Authorization Form - Spanish

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

PDFHealthcare Provider Request Form

PDFPatient Authorization Form

PDFHealthcare Provider Request Form - Spanish

PDFPatient Authorization Form - Spanish

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Tukysa patient education

Getting started on Tukysa

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link